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Faciogenital dysplasia protein (FGD1) and Vav, two related
proteins required for normal embryonic development, are
upstream regulators of Rho GTPases
Michael F. Olson*†, N. German Pasteris‡, Jerome L. Gorski‡ and Alan Hall*
Background: Dbl, a guanine nucleotide exchange factor (GEF) for members of
the Rho family of small GTPases, is the prototype of a family of 15 related
proteins. The majority of proteins that contain a DH (Dbl homology) domain were
isolated as oncogenes in transfection assays, but two members of the DH family,
FGD1 (the product of the faciogenital dysplasia or Aarskog–Scott syndrome
locus) and Vav, have been shown to be essential for normal embryonic
development. Mutations to the FGD1 gene result in a human developmental
disorder affecting specific skeletal structures, including elements of the face,
cervical vertebrae and distal extremities. Homozygous Vav–/– knockout mice
embryos are not viable past the blastocyst stage, indicating an essential role of
Vav in embryonic implantation.
Results: Here, we show that the microinjection of FGD1 and Vav into Swiss 3T3
fibroblasts induces the polymerization of actin and the assembly of clustered
integrin complexes. FGD1 activates Cdc42, whereas Vav activates Rho, Rac and
Cdc42. In addition, FGD1 and Vav stimulate the mitogen activated protein
kinase cascade that leads to activation of the c-Jun kinase SAPK/JNK1.
Conclusions: We conclude that FGD1 and Vav are regulators of the Rho
GTPase family. Along with their target proteins Cdc42, Rac and Rho, FGD1 and
Vav control essential signals required during embryonic development.
Background
The Rho GTPase family of small molecular weight GTP-
binding proteins control important aspects of cell shape,
adhesion, movement and growth. Rho, Rac and Cdc42
control three distinct signal transduction pathways in
Swiss 3T3 fibroblast cells: Rho regulates the assembly of
actin stress fibres and focal adhesion complexes; Rac con-
trols the formation of lamellipodia and membrane ruffles
by stimulating peripheral actin polymerization and the
assembly of small integrin complexes; and Cdc42 induces
actin-rich filopodial extensions, which are also associated
with clustered integrin complexes [1–3].
In addition to their roles in regulating the actin
cytoskeleton, it has been demonstrated recently that Rho
GTPases are involved in the regulation of cell growth. The
microinjection of activated forms of Rho, Rac and Cdc42
into quiescent fibroblasts stimulates progression through
the cell cycle, leading to new DNA synthesis [4], and all
three GTPases are required for the serum-stimulated mito-
genic response of fibroblasts [4–6]. One mechanism
whereby the Rho GTPases could control growth is by their
newly described function as regulators of RNA transcrip-
tion. Cdc42 and Rac, but not Rho, regulate a mitogen-acti-
vated protein (MAP) kinase cascade that leads to the
activation of the stress-activated protein kinase (SAPK, also
known as the Jun N-terminal protein kinase or JNK)
[4,7–10]. In addition, Rho, Rac and Cdc42 have been shown
to be involved in mediating the activity of the serum
response factor (SRF) signalling pathway, which links a
variety of stimuli to the transcriptional activation of genes
that contain the serum response element (SRE) [11].
Small molecular weight GTPases are switched on by
guanine nucleotide exchange factors (GEFs), which convey
information from upstream by promoting the exchange of
GDP for GTP. In the case of Rho GTPases, it is believed
that the Dbl homology (DH) protein family are the cellular
Rho GEFs; indeed, a number of DH proteins have been
shown to act as GEFs in vitro [12]. The DH family com-
prises a number of proteins that share two conserved
domains — a DH domain of approximately 250 amino
acids, and a pleckstrin homology (PH) domain of approxi-
mately 100 amino acids. Two members of the DH protein
family, FGD1 and Vav, play essential roles in embryonic
development: FGD1 was determined by positional cloning
to be the genetic locus responsible for faciogenital dysplasia
or Aarskog–Scott syndrome, a multisystemic developmental
disease involving the skeletal and urogenital systems [13];
and homozygous Vav–/– knockout mice embryos could not
be detected at mid-gestation stages E7.5 to E12.5, indicat-
ing the importance of Vav for normal embryogenesis [14].
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In this study, we sought to determine whether FGD1 and
Vav could activate Rho GTPases in vivo. By microinjecting
plasmids encoding epitope-tagged versions of DH proteins
into Swiss 3T3 fibroblasts and examining the effects on the
polymerization of actin and the assembly of clustered inte-
grin complexes, we found that FGD1 activates Cdc42,
whereas Vav activates Rho, Rac and Cdc42. FGD1 and Vav
also stimulate the MAP kinase cascade that leads to activa-
tion of the c-Jun kinase SAPK/JNK1, but do not stimulate
the Ras-regulated MAP kinase cascade that leads to ERK2
activation. These results are consistent with the actions of
FGD1 and Vav being specific for members of the Rho
GTPase family.
Results and discussion
To determine whether FGD1 or Vav can activate members
of the Rho GTPase family, sequences encoding the adja-
cent DH and PH domains of the two proteins and an
amino-terminal Myc epitope tag were introduced into a
eukaryotic expression vector (pRK5; see Fig. 1). As con-
trols, the corresponding regions of two additional GEFs,
Dbl and Lbc, were introduced into epitope-tagged expres-
sion vectors (Fig. 1). (It has been shown, both in vitro and in
vivo, that Lbc activates only Rho and that, in vitro, Dbl acti-
vates Rho and Cdc42 and possibly Rac [15–18].) The result-
ing vectors were microinjected into the nuclei of quiescent
Swiss 3T3 cells.
As reported previously [15], uninjected quiescent cells
contain very little organized polymerized actin (Fig. 2), but
injection of pSR-Lbc induces the formation of a dense
network of actin stress fibres (Fig. 2). Coinjection of pSR-
Lbc with the Rho inhibitor C3 transferase completely
blocks all Lbc-induced effects [15]. The effects of injecting
pRK5-Dbl or pRK5-Vav were indistinguishable from each
other (Fig. 2): cells had prominent actin stress fibres and
contained pronounced peripheral lamellipodia. Time-lapse
video recordings showed a dramatic induction of membrane
ruffling by Dbl and Vav (data not shown). We conclude that
Vav, like Dbl, promotes guanine nucleotide exchange on
Rho, and that both are potent activators of Rac — although
the mechanism could be direct, or indirect via Cdc42 [3].
The injection of cells with pRK5-FGD1 produced a
different and distinct effect from that induced by
expression of Lbc, Vav or Dbl, as no stress fibres or overt
lamellipodia were observed (Fig. 2). Instead, the injected
cells showed large numbers of striking filopodial
extensions; we conclude that FGD1 promotes nucleotide
exchange on Cdc42, but not Rac or Rho. Closer inspection
of pRK5-FGD1-injected cells revealed restricted lamel-
lipodial extensions associated with filopodia, consistent
with a localized activation of Rac by Cdc42, as described
previously [3]. Time-lapse video recordings of pRK5-
FGD1-injected cells revealed a rather complicated pattern
of behaviour — filopodial extensions grew out of the cell
periphery and then either retracted or gradually became
subsumed under a growing lamellipodia, which then
detached and ‘ruffled’ back into the cell body. 
The FGD1 gene has been found to give rise to an additional
alternatively spliced transcript in embryonic tissues, which
encodes a slightly shorter form of the protein lacking 36
amino acids near the amino-terminal end of the DH domain
(N.G. Pasteris and J.L. Gorski, unpublished observations).
To determine whether this alternatively spliced form of
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Figure 1
Schematic diagram of the DH proteins Dbl,
Vav and FGD1, and the eukaryotic expression
vectors constructed. For Lbc, the structure of
only onco-Lbc is available. Structural domains
of the proteins are abbreviated as follows:
DH, Dbl homology; PH, pleckstrin homology;
Cys, cysteine-rich, zinc finger-like; SH3, Src
homology 3; SH2, Src homology 2; Pro,
proline-rich. Numbers refer to amino-acid
residues. In the text, the vectors are
abbreviated: for example, pRK5-myc-Dbl is
denoted as pRK5-Dbl, and pSRneo-FLAG-
Lbc as pSR-Lbc.
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FGD1 could also affect the actin cytoskeleton, the corre-
sponding sequences were introduced into the pRK5 expres-
sion vector (pRK5-FGD1D, Fig. 1) and injected into cells.
Although the product was clearly expressed, no induction of
polymerized actin could be observed, consistent with the
DH domain being responsible for activation of Cdc42.
In addition to their effects on actin, Rho, Rac and Cdc42
induce the assembly of discrete integrin complexes that
can be visualized using an anti-vinculin antibody [1,3].
Uninjected cells had very few vinculin-containing com-
plexes (data not shown), but the injection of pRK5-Lbc
induced numerous focal adhesions, consistent with the
activation of Rho (Fig. 3). Dbl- and Vav-expressing cells
showed a combination of focal adhesions and Rac-
dependent peripheral focal complexes, whereas FGD1
induced vinculin complexes localized predominantly along
filopodial extensions [3].
To confirm that FGD1 acts only upon Cdc42, and to deter-
mine whether Vav activates Rac and/or Cdc42, we used the
Cdc42-binding domain of WASP (the protein product of
the Wiskott–Aldrich syndrome locus). This domain inter-
acts specifically with the GTP-bound form of Cdc42
[19,20] and, when injected into cells, inhibits the Cdc42-
mediated signal transduction pathway [21]. Microinjection
of WASP markedly attenuated FGD1-induced effects, but
had no inhibitory effect on Lbc (Fig. 4). We conclude that
FGD1 specifically promotes guanine nucleotide exchange
on Cdc42. 
As both Vav and Dbl produced such dramatic lamellipodial
spreading compared with FGD1 (Fig. 2), it seemed likely
that these two proteins were able to activate Rac directly. In
agreement with this prediction, the co-injection of WASP
with DNA encoding Dbl or Vav had no significant
inhibitory effect on either stress fibre or lamellipodia
formation (Fig. 4); we conclude that Dbl and Vav can acti-
vate both Rho and Rac directly. In vitro assays have demon-
strated that Dbl catalyzes nucleotide exchange on Rho and
Cdc42, although there have been conflicting reports as to
whether it has activity on Rac [17,18]. Although no obvious
Figure 2
Lbc, Dbl, Vav and FGD1 promote
polymerization of actin in quiescent Swiss 3T3
fibroblasts. Serum-starved Swiss 3T3 cells
were microinjected with plasmid DNA
encoding epitope-tagged DH proteins, as
indicated. Actin cytoskeletal structures in cells
expressing the DH protein constructs (data
not shown) were visualized with TRITC-
conjugated phalloidin. Scale bar in (a)
represents 20 mm and refers to all panels in
all figures.
Figure 3
Lbc, Dbl, Vav and FGD1 induce the assembly
of clustered integrin complexes in quiescent
Swiss 3T3 cells. Serum-starved Swiss 3T3
fibroblasts were microinjected with plasmid
DNA encoding epitope-tagged DH proteins,
as indicated, along with Texas-Red
conjugated dextran as an injection marker.
Vinculin distribution was visualized with a
monoclonal anti-vinculin antibody (VIN-11-5).
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filopodia were induced by Dbl, these are difficult to see in
Swiss 3T3 cells when Rac is strongly activated. To deter-
mine whether Dbl and Vav activate Cdc42 in vivo, a domi-
nant-negative version of Rac (N17Rac) was used. When
Dbl or Vav were expressed in cells in the presence of
N17Rac, filopodial extensions were revealed in addition to
stress fibres (Fig. 4); in contrast, no filopodial extensions
were observed when N17Rac was microinjected alone (data
not shown). We conclude, therefore, that Dbl and Vav
stimulate Rho, Rac and Cdc42 independently.
It has been demonstrated that Cdc42 and Rac, but not
Rho, regulate a MAP kinase cascade that leads to the acti-
vation of SAPK/JNK [4,7–10]. In addition, it has been
shown that Dbl is capable of stimulating this protein
kinase cascade, consistent with the activation of Rac and/or
Cdc42 [7]. We wished to determine whether FGD1 and
Vav could also activate the SAPK/JNK signal transduction
cascade. A transient transfection protocol was used in
which COS-1 monkey kidney cells were co-transfected
with DNA encoding Dbl, Vav or FGD1, together with
DNA encoding SAPK/JNK1 tagged with a FLAG epitope
(Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys). After 48 hours,
SAPK/JNK1 was immunoprecipitated and its activity
towards the substrate c-Jun determined in an in vitro
kinase assay. As shown previously, a constitutively acti-
vated Cdc42 (L61Cdc42), Dbl and the carboxy-terminal
domain of the upstream kinase MEKK each stimulated
kinase activity (Fig. 5a). FGD1 and Vav also stimulated
SAPK/JNK1 activity. 
Vav has been reported to be an activator of Ras [22–26],
although this has not been confirmed by others [27–30]. It
has also been reported that Vav- and Dbl-transformed cell
lines have elevated ERK2 MAP kinase activity [27]. Using
COS cell transfections, we tested the ability of Dbl, Vav
and FGD1 to activate the Ras signal transduction pathway
leading to ERK2 MAP kinase activation. COS-1 cells were
cotransfected with DNA encoding Myc-epitope-tagged
ERK2 along with activated Ras (D12Ras), Dbl, Vav or
FGD1; we also used a membrane-targeted form of the
known Ras exchange factor, Sos. As expected, D12Ras and
Sos stimulated the kinase activity of immunoprecipitated
ERK2, but despite comparable amounts of ERK2 being
immunoprecipitated (data not shown), Dbl, Vav and FGD1
showed no increase in ERK2 activity (Fig. 5b). These
results indicate that Dbl, Vav and FGD1 specifically acti-
vate members of the Rho GTPase family. Consistent with
the results presented here, Crespo et al. [31] have recently
reported that expression of Vav in COS-7 cells leads to the
activation of SAPK/JNK1 but not ERK2. However, this
group reported that SAPK/JNK1 activation was decreased
by coexpression of N17Rac but not by co-expression of
N17Cdc42, suggesting that Vav stimulates Rac and not
Cdc42. Our data show that the effects of Vav and Dbl on
Figure 4
Inhibition of Cdc42 and Rac with a fragment
of WASP and N17Rac, respectively. Serum-
starved Swiss 3T3 fibroblasts were
microinjected with plasmid DNA encoding
epitope-tagged DH proteins, along with the
bacterially expressed Cdc42-binding domain
of WASP (residues 201–321) or bacterially
expressed N17Rac as indicated. Actin
cytoskeletal structures in cells expressing the
DH protein constructs (data not shown) were
visualized with TRITC-conjugated phalloidin.
Figure 5
Effect of Dbl, Vav and FGD1 on SAPK/JNK1 and ERK2 MAP kinase
pathways. COS-1 cells were co-transfected with epitope-tagged
SAPK/JNK1 (a) or ERK2 (b) along with expression vectors for DH
proteins and controls as indicated. SAPK/JNK and ERK2 kinases were
immunoprecipitated from cell lysates and assayed in vitro for their
ability to phosphorylate GST-c-Jun or myelin basic protein (MBP),
respectively. Experiments were carried out in triplicate and
representative assays are shown. Comparable amounts of SAPK/JNK1
in (a) or ERK2 in (b) were immunoprecipitated (data not shown)
– MEKK L61Rac DbI Vav FGD1
– D12Ras DbI Vav FGD1 Sos
(a)
(b)
GST-c-JUN
MBP
the actin cytoskeleton are indistinguishable and, as Dbl has
been shown to be an exchange factor for Cdc42 in vitro, we
conclude that Vav activates Cdc42 as well as Rac and Rho.
Conclusions
The results presented here show that, like Dbl and Lbc,
the DH family proteins FGD1 and Vav specifically
promote guanine nucleotide exchange on members of the
Rho GTPase family. Because of the indirect nature of the
assays used in this study, it remains to be seen whether the
activation of the Rho GTPases is mediated solely by FGD1
and Vav, or whether additional accessory proteins are
required. We have been unable to express recombinant Vav
or FGD1 protein in Escherichia coli for direct examination of
guanine nucleotide exchange activity in vitro.
DH proteins appear to regulate Rho GTPases with either
a restricted specificity (FGD1 and Lbc) or with a broad
specificity (Dbl and Vav) (Fig. 6). Mutations to FGD1,
either by interruption of the gene by chromosomal translo-
cation or by insertion of a single base pair resulting in pre-
mature translational termination within the DH domain
[13], have been detected in human patients suffering from
faciogenital dysplasia or Aarskog–Scott syndrome. The
predicted loss of FGD1 is associated with a specific and
characteristic pattern of skeletal anomalies, which affects
embryogenesis and alters the size of small bones and
cartilage elements in the face, distal extremities, and
vertebrae [32,33]. Our results suggest that a signal trans-
duction pathway controlled by FGD1/Cdc42 may play a
crucial role in skeletal development. Vav–/– mouse
embryos die at around E7.5 prior to implantation. As tro-
phoblast cells must migrate from embryonic to maternal
tissue and invade the uterine wall it is possible that the
activation of Rac and Cdc42 by Vav may be required for
cell migration or invasion, two processes that have been
associated with Rac activation in other circumstances [34].
Materials and methods
DNA constructs
Myc-epitope tagged Dbl (residues 495–826), Vav (residues 145–598),
FGD1 (residues 391–710) and FGD1D (residues 391–710,
D398–433) were introduced into the cytomegalovirus (CMV) promoter
based vector, pRK5 [35], by PCR using the following sets of oligonu-
cleotide pairs: Dbl, GGGGGATCCTTAAAGAACCACGTA and
GGGGATCCTCATAATTGATCCTGTTG; Vav, GGGGGATCC-
CTTTCAGACCAGATT, and GGGAATTCTCACACTTCCATCTTAGG;
FGD1 and FGD1D, CTGGGATCCTTTCACATTGCCAATGAGCTC,
and GCAGGAATTCTAGTCTTCATCTTCCCTGTT. pRK5 was modi-
fied by ligating the following annealed oligos into the EcoRI and PstI
sites to create a Myc-epitope tag followed by a multiple cloning site:
sense oligo, AATTGGCCACCATGGAGCAGAAGCTGATCTCCGAG-
GAGGACCTGGGATCCCGGGTCTAGAATTCCTGCA; antisense
oligo GGAATTCTAGACCCGGGATCCCAGGTCCTCCTCGGA-
GATCAGCTTCTGCTCCATGGTGGCC. All constructs were verified
by DNA sequencing. The pSRneo-FLAG-Lbc plasmid was a gift from D.
Toksoz [15]. DNA for microinjection was prepared by a standard CsCl
gradient purification method. All DNA manipulations followed standard
protocols [36].
Mammalian cell culture
Swiss 3T3 fibroblasts were maintained in DMEM (BRL/Life Technolo-
gies) supplemented with 10 % fetal calf serum, penicillin and strepto-
mycin (Sigma), as described [3]. Cells were allowed to reach
confluence and, 7–10 days after seeding, cells were serum-starved for
16 h by removing medium and replacing with serum-free medium con-
taining 0.2 % NaHCO3. Quiescent serum-starved Swiss 3T3 fibrob-
lasts were briefly trypsinized, resuspended in serum-free medium
containing 0.5 mg ml–1 soybean trypsin inhibitor (Sigma), plated at low
density in serum-free medium onto 13 mm glass coverslips that had
been coated with 50 mg ml–1 fibronectin (Sigma) and allowed to attach
for 30–60 min prior to microinjection.
COS-1 cells were cultured in DMEM containing 10 % fetal calf serum
as described [37]. For transient transfections, cells were trypsinized
and plated at 5 × 105 cells per 100 mm dish in DMEM supplemented
with 10 % NuSerum (Collaborative Biomedical Products).
Microinjection and immunofluorescence
Plasmid DNA (0.1 mg ml–1) was microinjected into the nuclei of Swiss
3T3 fibroblasts and, 2–3 h later, cells were fixed in 4 % paraformalde-
hyde for 15 min, and permeabilized with 0.5 % Triton X-100 for 15 min.
Expressed protein was visualized by incubating for 1 h with the Myc-
epitope antibody (9E10) or the FLAG-epitope antibody (M2; Kodak)
followed by incubation for 45 min with FITC-conjugated goat anti-
mouse antibody (Sigma). Actin structures were visualized by incubating
with 0.1 mg ml–1 TRITC-conjugated phalloidin (Sigma) for 45 min.
Texas-Red conjugated dextran (2 mg ml–1; Molecular Probes) was
included with DNA as an injection marker in experiments examining vin-
culin distribution. Cells were fixed and permeabilized as described
above, then treated with 1 mg ml–1 sodium borohydride (Sigma) for
10 min. Vinculin was visualized by incubation for 1 h with a monoclonal
anti-vinculin antibody (anti-vinculin clone VIN-11-5, Sigma) followed
sequentially by FITC-conjugated goat anti-mouse antibody (1 h) and
then FITC donkey anti-goat antibody (1 h).
Plasmid DNA encoding Dbl, Lbc, Vav or FGD1 (0.1 mg ml–1) were
coinjected with bacterially expressed GST–WASP (6 mg ml–1) or
N17Rac (0.4 mg ml–1) and stained for protein expression and actin
structures as described above.
Cells were photographed using a Zeiss Axiophot microscope with
TMY-400 film (Kodak).
Protein expression
N17Rac and the Cdc42-binding domain of WASP (residues
201–321) were produced as recombinant GST-fusion proteins in
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Figure 6
Schematic representation of the Rho GTPases activated by Lbc, Dbl,
Vav and FGD1. Dbl and Vav appear to regulate Rho, Rac and Cdc42.
The specificity of FGD1 and Lbc is more restricted: Lbc only activates
Rho, and the actions of FGD1 are limited to Cdc42.
RacCdc42 Rho
Lbc
Stress Fibres
FGD1
Lamellipodia
SAPK/JNK
Filopodia
SAPK/JNK
Dbl
Vav
E.coli as described [3,19] and N17Rac released from GST by
thrombin treatment.
Transient transfection and kinase assays
Transient transfection of COS-1 cells was carried out as described
[36]. Plasmid concentrations per 10 cm petri dish were as follows: for
SAPK/JNK1 assays: 10 mg pCMV-FLAG-JNK1 and 5 mg each of pMT-
myc-MEKK carboxy-terminal domain, pEXV-myc-L61cdc42, pRK5-myc-
Dbl, pRK5-myc-Vav and pRK5-myc-FGD1; for ERK assays: 10 mg
pEXVmyc-ERK2 and 5 mg each of pEXV-myc-D12ras, pRK5-myc-Dbl,
pRK5myc-Vav, pRK5-myc-FGD1 and pRK5-Sos. After incubation for
16 h in serum-free DMEM, cell lysates were harvested and assayed for
SAPK/JNK1 activity and for ERK2 activity as described [4]. Quantita-
tive western-blot analysis of the epitope-tagged proteins was carried
out using the monoclonal antibodies anti-myc 9E10 and anti-FLAG M2
and 125I-labelled protein A (Amersham). The levels of SAPK/JNK1 or
ERK2 immunoprecipitated were determined on western blots with M2
anti-FLAG antibody or 9E10 anti-myc antibody and alkaline-phos-
phatase conjugated anti-mouse antibody (Pierce). Experiments were
carried out in triplicate and representative assays are shown.
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